FDA Inspection
Reliance Life Sciences Private LimitedReliance Life Sciences Private Limited – FDA Inspection, Feb 27, 2026
Record Details
This FDA Inspection record concerns Reliance Life Sciences Private Limited, with an inspection on February 27, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- February 27, 2026
- Product Type
- Human Drugs
View Company Profile
ID · ccab4917-175f-46db-ad0c-ba158ab3159d
Inspection Facts
- Inspection number
- 1311632
- FDA center
- Human Drugs
Other FDA inspections of Reliance Life Sciences Private Limited
9| Date | Classification | Office | Project area |
|---|---|---|---|
| April 15, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| November 22, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 22, 2019 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| October 16, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 25, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Reliance Life Sciences Private Limited
- FDA Inspection 1170339 - 2022-04-15
- FDA Inspection 1113122 - 2019-11-22
- FDA Inspection 1081821 - 2019-02-22
- FDA Inspection 1070144 - 2018-10-16
- FDA Inspection 1047623 - 2018-01-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.